Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey.
Day
Carolyn A
CA
Drug Health Services, Central Clinical School, University of Sydney, NSW, Australia. cday@med.usyd.edu.au
Topp
Libby
L
Iversen
Jenny
J
Maher
Lisa
L
D000328:Adult; D045930:Anabolic Agents / Q000008:administration & dosage*; D001315:Australia / Q000453:epidemiology; D017848:Blood-Borne Pathogens; D005260:Female; D015658:HIV Infections / Q000453:epidemiology; D006509:Hepatitis B / Q000453:epidemiology; D006801:Humans; D008297:Male; D018671:Needle-Exchange Programs / Q000706:statistics & numerical data*; D015995:Prevalence; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000097:blood / Q000453:epidemiology / Q000821:virology*
D045930:Anabolic Agents